Vaccine: Martin Kenyon recalls receiving Covid jab
Coronavirus vaccines are being hailed as a huge step towards normality. A 90-year-old grandmother of four from Northern Ireland was the first person to be vaccinated in the world outside of trial conditions. But how will the vaccine affect people with allergies?
The NHS has now launched the biggest mass vaccination in history issuing a jab which protects against Covid-19.
The Pfizer/BioNTech was found to be safe and effective by the UK medicines regulator last week and has been approved for mass use.
The UK has ordered 40 million doses of the vaccine, which is enough to vaccinate 20 million people.
So far, hundreds of Britons have been vaccinated and many more are expected to be vaccinated throughout this month.
Two other vaccines are in development and could soon be ready for widespread use.
We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.
The Joint Committee on Vaccination and Immunisation (JCVI) has published a list of nine high-priority groups accounting for around a quarter of the UK population.
The priority list is as follows:
- Residents in care homes for older adults and their carers, 80-year-olds and over and frontline health and social care workers
- 75-year-olds and over
- 70-year-olds and over and clinically extremely vulnerable individuals
- 65-year-olds and over
- 16 to 64-year-olds with serious underlying health conditions
- 60-year-olds and over
- 55-year-olds and over
- 50-year-olds and over.
What is in the vaccine?
The Government has published information about the Covid-19 vaccine BNT162b2, which is the Pfizer/BioNTech vaccine which is currently being given to those in the highest priority threshold.
The vaccine’s active substance is BNT162b2 RNA.
After dilution, the vial contains five doses of 0.3ml with 30 micrograms mRNA each.
The other ingredients are listed as:
- ALC-0315 = (4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)
- ALC-0159 = 2[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide,
- 1,2-Distearoyl-sn-glycero-3-phosphocholine
- Cholesterol
- Potassium chloride
- Potassium dihydrogen phosphate
- Sodium chloride
- Disodium hydrogen phosphate dihydrate
- Sucrose.
DON’T MISS
Tragic toll of the 688 healthcare heroes lost to coronavirus [PICTURES]
Pimlico plumbers boss furious at people not taking vaccine [INSIGHT]
Chief scientific adviser says face masks may be needed until next year [ANALYSIS]
What allergies could be affected by the vaccine?
Around one in 900,000 people have severe allergic reactions known as anaphylaxis to the vaccine.
An allergic reaction to a vaccine is very rare, but the NHS has advised people to speak to their doctor if they have known allergies involving eggs or gelatin for example.
University of Oxford vaccinology professor Sarah Gilbert told the Today programme: “What we should take away from it is that the vaccine is safe, it’s highly effective and one really important finding is that from 21 days after being given the first dose of the vaccine, nobody was admitted to hospital with Covid or had severe Covid disease.
“So, that’s a really important finding.
“We also report on the efficacy against symptomatic PCR-confirmed Covid – so that is a milder form of the disease where people aren’t needing to go into hospital – and, on average, the efficacy was 70 percent against that.
“But in a subgroup who had a half dose of the vaccine first followed by a full dose, it was 90 percent.”
Some people may be unable to receive vaccines because they will be allergic to one of the ingredients used to make the jab.
The Government’s website reads: “The vaccines do not contain living organisms, and so are safe for people with disorders of the immune system.
“These people may not respond so well to the vaccine.
“A very small number of people who are at risk of COVID-19 cannot have the vaccine – this includes people who have severe allergies to a component in the vaccine.”
Who else cannot have the vaccine?
The JCVI “favours a precautionary approach” to pregnant women getting the coronavirus vaccine developed by Pfizer and BioNTech.
Pregnant women are instead advised to wait to have the vaccine until after they have given birth.
This is because there is a lack of evidence about how it may impact expectant mothers as pregnant women were not included in trials.
The JCVI said: “There are no data as yet on the safety of Covid-19 vaccines in pregnancy, either from human or animal studies.
“Given the lack of evidence, the JCVI favours a precautionary approach and does not currently advise Covid-19 vaccination in pregnancy.
“Women should be advised not to come forward for vaccination if they may be pregnant or are planning a pregnancy within three months of the first dose.”
Children under the age of 16 are also not permitted to get the vaccine because there is a lack of evidence it is safe for those under 16.
Most children infected with Covid-19 are either asymptomatic or experience mild symptoms.
The JCVI said: “The committee advises that only those children at very high risk of exposure and serious outcomes, such as older children with severe neuro-disabilities that require residential care, should be offered vaccination.”
Source: Read Full Article